ask="58.87"
ask_size="500"
average_daily_volume="393016"
bid="51.46"
bid_size="100"
book_value="14.89"
change="+1.97"
change_from_200_day_moving_average="2.18"
change_from_50_day_moving_average="-2.20"
change_from_52_week_high="-9.25"
change_From_52_week_low="23.72"
change_in_percent="+3.96%"
close="51.73"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.81"
eps_estimate_next_year="-3.17"
ex_dividend_date="N/A"
float_shares="23975000"
high="52.10"
high_52_weeks="60.98"
last_trade_date="1/6/2017"
last_trade_price="51.73"
last_trade_size="16439"
last_trade_time="4:00pm"
low="49.98"
low_52_weeks="28.01"
market_capitalization="1.40B"
moving_average_200_day="49.55"
moving_average_50_day="53.93"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="58.50"
open="50.00"
pe_ratio="5.78"
peg_ratio="0.37"
percent_change_from_200_day_moving_average="+4.39%"
percent_change_from_50_day_moving_average="-4.09%"
percent_change_from_52_week_high="-15.17%"
percent_change_from_52_week_low="+84.68%"
previous_close="49.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.34"
price_per_sales="3.50"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.50"
stock_exchange="NMS"
symbol="FPRX"
volume="433980"
weeks_range_52="28.01 - 60.98"
